Magnesium supplementation for migraine prophylaxis
- PMID: 41216917
- PMCID: PMC12604082
- DOI: 10.1002/14651858.CD016307
Magnesium supplementation for migraine prophylaxis
Abstract
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the benefits and harms of magnesium supplementation for preventing episodic or chronic migraine in children and adults compared to usual pharmacological treatment or placebo. Secondary objective To evaluate the benefits and harms of magnesium supplementation in different groups, specifically in terms of equity-related characteristics such as economic status, age, or sex.
Copyright © 2025 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The Cochrane Collaboration.
Conflict of interest statement
JPR: none known
EQ: none known
LBV: none known
CMEL: none known
LIG: none known
References
-
- Olesen J. The International Classification of Headache Disorders. Headache. 2008;48(5):691-3. - PubMed
-
- Al-Hashel JY, Abokalawa F, Toma R, Algubari A, Ahmed SF. Worsening of migraine headache with fasting Ramadan. Clinical Neurology and Neurosurgery 2021;209:106899. - PubMed
-
- Ashina M. Migraine. New England Journal of Medicine 2020;383:1866-76. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
